[Clinical study with glypentide, new sulfonylurea hypoglycemic agent].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001835:Body Weight / Q000187:drug effects; D002986:Clinical Trials as Topic; D003517:Cyclopentanes / Q000031:analogs & derivatives / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D003517:Cyclopentanes; D013453:Sulfonylurea Compounds
Estudio clínico con glipentida, nueva sulfonilurea hipoglucemiante